IceCure Medical Ltd. Files Notice of Meeting and Proxy Statement
Ticker: ICCM · Form: 6-K · Filed: Jul 16, 2025 · CIK: 1584371
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, filing-update
Related Tickers: ICCU
TL;DR
IceCure Medical (ICCU) filed a 6-K for a shareholder meeting notice. No new financials, just governance.
AI Summary
IceCure Medical Ltd. filed a Form 6-K on July 16, 2025, to report its Notice of Meeting and Proxy Statement. This filing is a routine report for foreign private issuers and does not contain specific financial or operational updates beyond the announcement of the meeting details.
Why It Matters
This filing indicates that IceCure Medical Ltd. is holding a shareholder meeting, which is a standard corporate governance procedure. It may precede significant corporate decisions or updates.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not present new financial risks or significant operational changes.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- July 16, 2025 (date) — Filing Date
- Form 6-K (document) — Filing Type
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report IceCure Medical Ltd.'s Notice of Meeting and Proxy Statement.
When was this filing submitted to the SEC?
This filing was submitted to the SEC on July 16, 2025.
Is IceCure Medical Ltd. required to file Form 20-F or Form 40-F annually?
Yes, IceCure Medical Ltd. indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for IceCure Medical Ltd.?
The principal executive office address is 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
What is the Commission File Number for IceCure Medical Ltd.?
The Commission File Number for IceCure Medical Ltd. is 001-40753.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 16, 2025 regarding IceCure Medical Ltd. (ICCM).